IMS Solution, LLC
USPTO PatentsView assignee record - 6 granted patents across 11 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: Y10T (Technical Subjects Covered BY Former US Classification).
The verdict
According to USPTO PatentsView, IMS ranks #40,879 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 11 technology areas.
- #40,879
- of 49,997 US assignees by volume
- 25th percentile
- by Innovation Score (27.9/100)
- 15.7
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R40879 · US Corporation #40,879 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #40,879/49,997
- PHOTO-FINISH Impact Technology…
- CPC-FOCUS Y10T · 11 areas
- INNOV-THIN 27.9/100
- CLAIMS-RICH 15.7 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Impact Technology Systems AS (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How IMS’s 27.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around IMS
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- IMS Solution · this assignee 28
IMS Solution · this assignee
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows IMS's Innovation Score is 27.9/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for IMS?
Each dot is one of IMS’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). IMS’s own 15.7 claims/patent is at or below the 18.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where IMS's grants concentrate
IMS Solution, LLC is a focused PatentsView assignee: 11 CPC subclasses with 83.3% of grants classified under Y10T (Technical Subjects Covered BY Former US Classification). Peak complete grant year is 2016 (2 grants) versus a trough of 1 in 2015. By volume, IMS sits between Impact Technology Systems AS and Incospharm Corporation.
Who files at IMS's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Impact Technology…
Impact Technology Systems AS
6 patents
- Imperial Blades
Imperial Blades
6 patents
- Implementation Ap…
Implementation Apps LLC
6 patents
- Imprimis Pharmace…
Imprimis Pharmaceuticals, Inc.
6 patents
- IMV
IMV Corporation
6 patents
- Inceptio Hongkong
Inceptio Hongkong Limited
6 patents
- Incom
Incom, Inc.
6 patents
- Incospharm
Incospharm Corporation
6 patents
- IMS Solution ◀
IMS Solution, LLC
6 patents
What this shows IMS holds 6 patents at rank #40,846, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near IMS
By rank, the assignees closest to #40,846 in granted patent volume.
- Impact Technology Systems AS #40,842 · 6 patents
- Imperial Blades #40,843 · 6 patents
- Implementation Apps LLC #40,844 · 6 patents
- Imprimis Pharmaceuticals, Inc. #40,845 · 6 patents
- IMV Corporation #40,847 · 6 patents
- Inceptio Hongkong Limited #40,848 · 6 patents
- Incom, Inc. #40,849 · 6 patents
- Incospharm Corporation #40,850 · 6 patents
Leaders in Y10T (Technical Subjects Covered BY Former US Classification)
Other assignees with the most granted patents in IMS's primary technology class.
IMS's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 25th percentile higher than 25% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 2 | 33.3% |
| 2017 | 1 | 16.7% |
| 2018 | 1 | 16.7% |
| 2019 | 1 | 16.7% |
Which technologies does IMS Solution, LLC patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
IMS Solution, LLC's patent record in context - here's where to go next.
- IMS Solution, LLC's lead technology class is Y10T (Technical Subjects Covered BY Former US Classification), 83.3% of its portfolio - see every assignee active in that class. Explore Y10T
- Ranked #40,879 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare IMS Solution, LLC against Impact Technology Systems AS, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.